U
2024
Cardiac arrest is a serious medical condition wherein there is abrupt loss of heart function, breathing and consciousness. The condition usually results from an electrical disturbance in the ...
Report Code : A08079 | Category : Life Sciences
U
2024
Cardiac resynchronization therapy is a treatment for heart failure in patients with abnormal ventricular contraction. Heart muscles weaken due to heart failure resulting in inadequate blood pumping to ...
Report Code : A08080 | Category : Life Sciences
U
2024
Cardiac catheters is device which is widely used in cardiac catheterization, angioplasty, Percutaneous Coronary Intervention (PCI), and other interventional procedures. In the cardiac catheter helps to measuring heart ...
Report Code : A10387 | Category : Life Sciences
U
2024
An artificial heart valve or cardiac valve is a one-way valve implanted into the heart of a patient to replace a dysfunctional native heart valve (valvular heart disease). ...
Report Code : A11126 | Category : Life Sciences
U
2024
Cardiac surgery instruments are referred to as the instruments used in the procedure of cardiovascular surgery. It is the surgery performed on the heart by the cardiac surgeons. ...
Report Code : A11498 | Category : Life Sciences
U
2024
A range of treatments have been developed for the management of cardiac arrhythmias. These include antiarrhythmic drugs, artificial pacemakers, implanted cardiac defibrillators and ablation of damaged or malfunctioning ...
Report Code : A11909 | Category : Life Sciences
P
2020
The China 3D cardiac mapping market size was valued at $55.55 million in 2019, and is projected to reach $150.59 million by 2027, registering a CAGR of 12.8% from 2020 to 2027.
Report Code : A06517 | Pages : 75 | Category : Life Sciences
P
2020
The U.S. patient monitoring market was valued at $12,200.96 million in 2019, and is projected to reach $22,583.40 million by 2027, registering a CAGR of 5.21% from 2020 to 2027.
Report Code : A06822 | Pages : 200 | Category : Life Sciences
U
2024
Extracorporeal membrane oxygenation (ECMO) is a life supporting equipment and is used for patients suffering from severe and fatal illness that restricts the normal functioning of their heart or lungs and are not able to breathe properly.
Report Code : A08108 | Category : Life Sciences
P
2021
The U.S. cardiac resynchronization therapy market size was valued at $965.6 million in 2019, and is projected to reach $983.3 million by 2027, registering a CAGR of 4.9% from 2020 to 2027.
Report Code : A10292 | Pages : 109 | Category : Life Sciences
Register and Earn 500 Loyalty Points
An Email Verification Code has been sent to your email address!
Please check your inbox and, if you don't find it there, also look in your junk folder.